C.M. Bidwell & Associates’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-48
Closed -$491 524
2024
Q1
$491 Buy
48
+20
+71% +$205 ﹤0.01% 447
2023
Q4
$153 Buy
+28
New +$153 ﹤0.01% 482